|
|
||||||||
Ann Thorac Surg 1995;59:723-729
© 1995 The Society of Thoracic Surgeons
Division of Cardiovascular Surgery, Department of Clinical Biochemistry, and Center for Cardiovascular Research, The Toronto Hospital and the University of Toronto, Toronto, Ontario, Canada
Accepted for publication December 7, 1994.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Material and Methods |
|---|
|
|
|---|
|
Cardioplegia Groups
Patients were randomly assigned, by means of computer-generated randomization table, to one of three cardioplegic strategies (see Table 1
).
Blood cardioplegia was prepared by mixing four parts of oxygenated blood to each part of crystalloid solution [5] and was delivered via the Buckberg-Shiley Plus system (Sorin Biomedical Inc, Irvine, CA). The cardioplegic technique is depicted in Figure 1
. In all patients, cardiac arrest was achieved with an antegrade infusion of 500 mL of high-potassium cardioplegia (containing 27 mEq/L of potassium) delivered into the aortic root at a pressure of 70 mm Hg measured through a separate port of the cardioplegia cannula (Research Medical Inc, Midvale, UT). After cardiac arrest was achieved with the initial antegrade infusion, the aortic root was vented and retrograde delivery of low-potassium cardioplegia (containing 13 mEq/L) was commenced via an autoinflating coronary sinus cannula (Research Medical Inc) at a flow rate of 200 mL/min. Coronary sinus pressure was monitored continuously by a separate pressure-monitoring line, and maintained less than 40 mm Hg throughout the procedure. The adequacy of cannula positioning was confirmed by observing distention of the posterior interventricular vein, maintenance of coronary sinus pressure and palpation of the position of the coronary sinus cannula. The autoinflating coronary sinus catheter frequently required repositing after the construction of circumflex grafts. Distal and proximal anastomoses were constructed in an alternating manner. Antegrade cardioplegic infusions (250 mL) were given intermittently through the aortic root at a flow rate sufficient to maintain the aortic root pressure at 50 mm Hg after completion of each proximal saphenous vein graft anastomosis. The pressure measured in the coronary sinus during retrograde cardioplegia or in the aortic root during antegrade cardioplegia was recorded carefully and was used to calculate the coronary vascular resistance. Cardioplegic infusions were never given simultaneously by both routes. Cardioplegic flow was interrupted whenever necessary to achieve adequate visualization during the construction of the distal anastomoses. A ``catch-up'' infusion was given to maintain the average retrograde cardioplegic flow rate near 200 mL/min [6]. Patients were randomized to either cold (n = 14), tepid (n = 14), or warm (n = 14) cardioplegia, delivered at temperatures of 9°C, 29°C, or 37°C, respectively.
|
Oxygen, Lactate, and pH Assays
Arterial and coronary venous blood samples were obtained simultaneously on bypass before application of the cross-clamp, immediately after cross-clamp release, 10 minutes after cross-clamp removal, and 10 minutes after discontinuing cardiopulmonary bypass. During cross-clamping, cardioplegic and coronary venous blood samples were obtained immediately before the completion of proximal anastomoses during retrograde cardioplegia and 30 seconds after the initiation of intermittent antegrade cardioplegia. Coronary venous samples were taken from the coronary sinus during antegrade cardioplegic delivery and from the aortic root during retrograde cardioplegic delivery.
Blood samples were assayed for the partial pressure of oxygen (Po2) and carbon dioxide, pH (Acid-Base Laboratory, Radiometer, Copenhagen, Denmark), and oxygen saturation (Co-Oximeter, Instrumentation Laboratory Inc., Lexington, MA). Oxygen content (O2Con) was calculated from the formula: O2Con = 1.39 hemoglobin x S + 0.0031 Po2, where S is the oxygen saturation. Myocardial oxygen extraction was calculated as the arterial or cardioplegic oxygen content minus the coronary venous oxygen content. Measurements were made at 37°C and corrected to the myocardial temperature at the time of sampling, which was measured in the left anterior descending region with a temperature probe (Sorin Biomedical Inc) [35].
Blood samples for lactate concentration were mixed with a measured volume of 6% perchloric acid. Lactate concentration was measured in the protein-free supernatant by an enzymatic method (Rapid Lactate Stat Pack kit; Calbiochem-Behring, La Jolla, CA). Myocardial lactate extraction was calculated in the same manner as oxygen extraction. Negative lactate extraction was expressed as lactate production.
The concentration of hydrogen ion ([H+]) in the blood sample was determined by converting the measured pH value to [H+] by the formula [H+] = antilog (-pH). Measurements were made at 37°C and corrected to the myocardial temperature at the time of sampling. Myocardial acid production was calculated as the coronary venous effluent [H+] minus the arterial or cardioplegic [H+] [3, 4].
During the cardioplegic arrest myocardial consumption of oxygen, lactate release, and acid release were calculated as cardioplegic flow multiplied by the difference between the arterial and coronary venous content [35].
Hemodynamic Measurements
Heart rate (HR), mean arterial blood pressure (MAP), mean pulmonary artery pressure (MPA), mean right atrial pressure (RAP), and pulmonary capillary wedge pressure (PCWP) were measured. Cardiac output (CO) was measured in triplicate by the thermodilution technique. Derived hemodynamic indices were calculated as follows: cardiac index (CI) = CO/body surface area (L min-1 m-2); stroke index (SI) = CI/HR (mL min-1 m-2); left ventricular stroke work index = SI x (MAP - PCWP) x 0.0136 (g m/m2); and right ventricular stroke work index = SI x (MPA - RAP) x 0.0136 (g m/m2). These hemodynamic variables were measured before initiation of cardiopulmonary bypass and at 10 minutes, 1 hour, 4 hours, 12 hours, and 24 hours after cessation of cardiopulmonary bypass. An analysis of covariance was employed to compare left and right ventricular stroke work indices (the independent variable) between the three cardioplegic groups with preload (left and right atrial pressure) as the covariate. Postoperative volume repletion followed a standard protocol and was accomplished by individuals who were unaware of the intraoperative cardioplegic technique employed.
Creatine Kinase
An antibody inhibition technique was employed to measure the MB isozyme of creatine kinase (CK-MB). The sequential CK-MB measurements were performed 2, 4, 8, 16, 24, and 48 hours after cross-clamp release. Integration of the area under the concentration-time curve for CK-MB within the 48 hours postoperatively allowed calculation of the total CK-MB release, expressed as units x hours per liter [26]. The CK-MB measurements of 1 patient in whom a new postoperative Q wave developed was excluded.
Statistical Analysis
Statistical analysis was performed with SAS program (SAS Institute, Cary, NC). One-way or two-way repeated measures analysis of variance was used to test the effect of cardioplegic group and time on myocardial oxygen utilization, lactate and acid metabolism, coronary vascular resistance, hemodynamic variables, and postoperative creatine kinase isoenzyme release. When analysis of variance indicated a significant effect of cardioplegic group or time (p < 0.05), the differences were specified with Duncan's multiple range test. Categoric data are displayed as the absolute and percent frequency. Continuous variables are listed as the mean and standard error of the mean. Statistical significance was assumed at a probability level of less than 0.05.
| Results |
|---|
|
|
|---|
Cardioplegic Flow Rates and Continuity
The initial antegrade cardioplegic infusion had similar flow rates between groups (cold, 288 ± 18 mL/min; tepid, 299 ± 16 mL/min; warm, 311 ± 16 mL/min; p = 0.60). There was no statistical difference in the mean cardioplegic flow rate during continuous retrograde cardioplegia (cold, 136 ± 7 mL/min; tepid, 148 ± 8 mL/min; warm, 160 ± 8 mL/min; p = 0.08). There was no significant difference in the frequency of infusion of intermittent antegrade cardioplegia (cold, 2.3 ± 0.2; tepid, 2.1 ± 0.2; warm, 2.3 ± 0.2 times per patient; p = 0.70). Intermittent antegrade cardioplegia was delivered at a flow rate sufficient to provide an aortic root pressure of 50 mm Hg. Differences in flow rates therefore represent differences in coronary vascular resistance. The flow rates of intermittent antegrade cardioplegia was greater in tepid or warm than in cold cardioplegia (cold, 216 ± 10 mL/min; tepid, 254 ± 9 mL/min; warm, 249 ± 12 mL/min; p < 0.05). The percentage of cross-clamp time during which cardioplegia was interrupted was similar between the groups (cold, 20% ± 4%; tepid, 16% ± 3%; warm, 20% ± 3%; p = 0.64).
Coronary Vascular Resistance
The mean aortic root pressure was similar between the groups during intermittent antegrade cardioplegia (cold, 51.4 ± 1.4 mm Hg; tepid, 50.5 ± 1.8 mm Hg; warm, 49.6 ± 1.8 mm Hg; p = 0.75), and coronary sinus pressures were similar during continuous retrograde cardioplegia (cold, 19.7 ± 1.2 mm Hg; tepid, 19.3 ± 1.4 mm Hg; warm, 18.5 ± 1.2 mm Hg; p = 0.79). Mean coronary vascular resistances during intermittent antegrade and continuous retrograde cardioplegia are shown in Figure 2
. The mean coronary vascular resistance was significantly greater with cold than with tepid or warm cardioplegia (p < 0.05) during intermittent antegrade cardioplegia and tended to be greater during continuous retrograde cardioplegia (p = 0.06).
|
|
Myocardial Metabolism During Reperfusion
Myocardial oxygen extraction, lactate production, and acid production before cross-clamping and during reperfusion are shown in Figure 4
. Myocardial oxygen extraction increased (p = 0.001) similarly in the three groups after cross-clamp removal. Myocardial lactate production (p = 0.02) and acid production (p = 0.02) were significantly greater immediately after cross-clamp release in the warm than in the tepid or cold cardioplegic groups.
|
|
Postoperative Release of the MB Isoenzyme of Creatine Kinase
There was no significant difference in total CK-MB release between groups (cold, 1,285 ± 96 U x h/L; tepid, 1,262 ± 129 U x h/L; warm, 1,152 ± 119 U x h/L; p = 0.69).
Clinical Outcomes
None of the patients died in this series of 42 patients. One patient suffered perioperative myocardial infarction (a new Q wave with a concomitant increase in CK-MB level) in the cold group. None of the patients had low output syndrome (defined as the requirement for inotropic support for more than 30 minutes despite optimization of preload and afterload) and none required an intraaortic balloon pump postoperatively. The incidence of these events was not statistically different between groups.
Although there were no statistically significant differences between the three cardioplegic groups for baseline variables (see Table 1
) we evaluated whether any of these variables could predict myocardial lactate or acid production at the time of cross-clamp removal (see Fig 4
). By univariate analyses none of the preoperative factors attained statistical significance. In addition, a multivariable analysis identified that only the cardioplegic group predicted lactate and acid production independent of the influences of other variables in Table 1
.
| Comment |
|---|
|
|
|---|
Retrograde coronary sinus cardioplegia has been proposed as a superior method to deliver cardioplegia to the myocardium distal to an occluded coronary artery [79]. However, venovenous shunting through arteriosinusoidal and thebesian communications may limit the nutritive retrograde cardioplegic flow to the right ventricular free wall and posterior ventricular septum [9, 10]. Warm retrograde cardioplegia decreased anaerobic lactate production when flow rates were increased from 50 to 200 mL/min [6]. However, further increases to 300 or 500 mL/min increased the shunt flow without reducing anaerobic lactate production. Warm retrograde cardioplegia resulted in greater anaerobic lactate production during and after cardioplegic arrest compared with other cardioplegic techniques [4, 11, 12]. To avoid ischemic myocardial damage during cardioplegic arrest and to restore immediate postoperative functional recovery, improved techniques of cardioplegic delivery are required.
Combination of Antegrade and Retrograde Cardioplegia
To overcome the limitations of either antegrade or retrograde cardioplegia alone, antegrade and then retrograde cold blood cardioplegia was given intermittently in animals [13] and patients [14, 15]. Intermittent infusions of antegrade and then retrograde cold blood cardioplegia every 20 minutes provided more homogeneous myocardial cooling, complete left and right ventricular functional recovery in animals, and excellent clinical outcomes in patients. However, this cardioplegic technique can not be employed for warm heart operations. We developed the technique of continuous warm retrograde cardioplegia with intermittent antegrade infusions for warm heart operations [3]. The technique reduced the accumulation of anaerobic metabolites and preserved myocardial adenosine triphosphate concentrations and ventricular function better than either antegrade or retrograde cardioplegia alone. In the present study, myocardial oxygen consumption increased with intermittent antegrade cardioplegia compared with continuous retrograde in all groups suggesting the repayment of an oxygen debt accumulated during retrograde cardioplegia. Lactate and acid release also increased during intermittent antegrade infusion compared with continuous retrograde infusions in the warm group suggesting the washout of anaerobic metabolites accumulated during warm retrograde cardioplegia. These findings are similar to the previous report in which we found that myocardial lactate release increased with time during warm retrograde but not warm combination cardioplegia [3].
Cardioplegic Temperature
The myocardial oxidation of glucose [16], lactate [16], and fatty acids [17] was depressed during and after cold cardioplegia. Cold cardioplegic arrest induced a defect in mitochondrial state 3 respiration and a decrease in citrate synthetase activity [18]. Furthermore, cold cardioplegia depressed metabolic activity and delayed ventricular functional recovery [2]. Therefore, cold cardioplegia will not permit resuscitation of the ischemic myocardium with the immediate restoration of ventricular function. Excessively cold cardioplegia also may cause coronary artery endothelial dysfunction [19]. Because coronary endothelial cells are more vulnerable than cardiomyocytes to ischemic injury, the measurements of coronary vascular resistance may be a sensitive index of metabolic and functional recovery. In the present study cold cardioplegia resulted in greater coronary vascular resistance than tepid or warm cardioplegic arrest. The delay of cardiac functional recovery after cold cardioplegia may be related to the endothelial dysfunction as well as cardiomyocyte mitochondrial dysfunction after hypothermic cardioplegic arrest.
Tepid cardioplegia produced a similar myocardial oxygen consumption to warm cardioplegia during cardioplegic arrest suggesting preservation of mitochondrial function. However, tepid cardioplegia reduced anaerobic lactate release compared with warm cardioplegia perhaps because myocardial metabolic demands were slightly reduced. Reducing the heart temperature to 29°C also provided a buffer to ischemic injury when cardioplegia was interrupted or inhomogeneous. Myocardial oxygen consumption was greater with tepid or warm than cold cardioplegia but anaerobic lactate and acid washout with intermittent antegrade cardioplegia were less with tepid or cold than warm cardioplegia. Lactate and acid washout were least after tepid and greatest after warm cardioplegia at the time of cross-clamp release. Furthermore, postoperative cardiac function was best preserved after tepid cardioplegia. These findings suggest that the combination of intermittent antegrade and continuous retrograde tepid cardioplegia provided superior myocardial protection when coronary obstructions or interruptions limited cardioplegic delivery.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. B. Albacker, R. Chaturvedi, A. H. Al Kindi, H. Al-Habib, T. Al-Atassi, B. de Varennes, and K. Lachapelle The effect of using microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery Interactive CardioVascular and Thoracic Surgery, July 1, 2009; 9(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Chambers Myocardial Infarction Comes Into the Cold! Ann. Thorac. Surg., January 1, 2009; 87(1): 8 - 10. [Full Text] [PDF] |
||||
![]() |
E. Bezon, J. N. Choplain, A. A. Aziz Khalifa, H. Numa, N. Salley, and J. A. Barra Continuous retrograde blood cardioplegia ensures prolonged aortic cross-clamping time without increasing the operative risk Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 403 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Flameng, P. Herijgers, S. Dewilde, and E. Lesaffre Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 121 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-E. Falcoz, D. Kaili, S. Chocron, G. Toubin, M. Puyraveau, J.-F. Viel, and J.-P. Etievent Warm and tepid cardioplegia: Do they provide equal myocardial protection? Ann. Thorac. Surg., December 1, 2002; 74(6): 2156 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Oka, M. Imamura, E. Hatta, R. Maruyama, M. Isaka, T. Murashita, and K. Yasuda Carrier-Mediated Norepinephrine Release and Reperfusion Arrhythmias Induced by Protracted Ischemia in Isolated Perfused Guinea Pig Hearts: Effect of Presynaptic Modulation by alpha 2-Adrenoceptor in Mild Hypothermic Ischemia J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, N. C. Pomroy, S.-H. Li, D. A. G. Mickle, R.-K. Li, and V. Rao Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1074 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verma, A. Maitland, R. D. Weisel, S.-H. Li, P. W. M. Fedak, N. C. Pomroy, D. A. G. Mickle, R.-K. Li, L. Ko, and V. Rao Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: Reversal with endothelin antagonism J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1120 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shiono, V. Rao, R. D. Weisel, M. Kawasaki, R.-K. Li, D. A. G. Mickle, P. W. M. Fedak, L. C. Tumiati, L. Ko, and S. Verma L-Arginine protects human heart cells from low-volume anoxia and reoxygenation Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H805 - H815. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Crittenden Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites Ann. Thorac. Surg., December 1, 2001; 72(6): S2220 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao, J. Ivanov, R. D. Weisel, G. Cohen, M. A. Borger, and D. A.G. Mickle Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery Ann. Thorac. Surg., June 1, 2001; 71(6): 1925 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruengsakulrach and B. F. Buxton Anatomic and hemodynamic considerations influencing the efficiency of retrograde cardioplegia Ann. Thorac. Surg., April 1, 2001; 71(4): 1389 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tian, B. Xiang, G. Dai, W. G. Lindsay, J. Sun, J. Shen, R. Summers, and R. Deslauriers The effects of retrograde cardioplegia technique on myocardial perfusion and energy metabolism: A magnetic resonance imaging and localized phosphorus 31 spectroscopy study in isolated pig hearts J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 544 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hayashida, S. Chihara, E. Tayama, S. Yokose, K. Akasu, E. Kai, and S. Aoyagi Effects of angiotensin-converting enzyme inhibitor during warm blood cardioplegia Ann. Thorac. Surg., August 1, 2000; 70(2): 627 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Oriaku, B. Xiang, G. Dai, J. Shen, J. Sun, W. G. Lindsay, R. Deslauriers, and G. Tian EFFECTS OF RETROGRADE CARDIOPLEGIA ON MYOCARDIAL PERFUSION AND ENERGY METABOLISM IN IMMATURE PORCINE MYOCARDIUM J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1102 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao, M. A. Borger, R. D. Weisel, J. Ivanov, G. T. Christakis, G. Cohen, and T. M. Yau INSULIN CARDIOPLEGIA FOR ELECTIVE CORONARY BYPASS SURGERY J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1176 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chocron, D. Kaili, Y. Yan, G. Toubin, L. Latini, F. Clement, J.-F. Viel, and J.-P. Etievent INTERMEDIATE LUKEWARM (20{degrees}C) ANTEGRADE INTERMITTENT BLOOD CARDIOPLEGIA COMPARED WITH COLD AND WARM BLOOD CARDIOPLEGIA J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 610 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cohen, M. A. Borger, R. D. Weisel, and V. Rao Intraoperative myocardial protection: current trends and future perspectives Ann. Thorac. Surg., November 1, 1999; 68(5): 1995 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M.F. Elwatidy, M. A. Fadalah, E. A. Bukhari, K. A. Aljubair, A. Syed, A. K. Ashmeg, and M. R. Alfagih Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG Ann. Thorac. Surg., August 1, 1999; 68(2): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Ericsson, S. Takeshima, and J. Vaage Warm or cold continuous blood cardioplegia provides similar myocardial protection Ann. Thorac. Surg., August 1, 1999; 68(2): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Cook Changing Temperature Management for Cardiopulmonary Bypass Anesth. Analg., June 1, 1999; 88(6): 1254 - 1254. [Full Text] [PDF] |
||||
![]() |
A. C. Fiore, M. T. Swartz, R. Nevett, P. J. Vieth, R. A. Magrath, A. Sherrick, and H. B. Barner Intermittent Antegrade Tepid Versus Cold Blood Cardioplegia in Elective Myocardial Revascularization Ann. Thorac. Surg., June 1, 1998; 65(6): 1559 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hayashida, T. Isomura, T. Sato, H. Maruyama, T. Higashi, K. Arinaga, and S. Aoyagi Minimally Diluted Tepid Blood Cardioplegia Ann. Thorac. Surg., March 1, 1998; 65(3): 615 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao, G. Cohen, R. D. Weisel, N. Shiono, Y. Nonami, S. M. Carson, J. Ivanov, M. A. Borger, R. J. Cusimano, and D. A. Mickle Optimal flow rates for integrated cardioplegia J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche Blood Cardioplegia: Do We Still Need to Dilute? Ann. Thorac. Surg., October 1, 1996; 62(4): 957 - 960. [Full Text] |
||||
![]() |
T. Shirai, V. Rao, R. D. Weisel, J. S. Ikonomidis, N. Hayashida, J. Ivanov, S. Carson, M. K. Mohabeer, and D. A. G. Mickle ANTEGRADE AND RETROGRADE CARDIOPLEGIA: ALTERNATE OR SIMULTANEOUS? J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 787 - 796. [Abstract] [Full Text] |
||||
![]() |
I. B. Krukenkamp and S. Levitsky Myocardial Protection: Modern Studies Ann. Thorac. Surg., May 1, 1996; 61(5): 1581 - 1582. [Full Text] |
||||
![]() |
J. S. Ikonomidis, V. Rao, R. D. Weisel, N. Hayashida, and T. Shirai Myocardial Protection for Coronary Bypass Grafting: The Toronto Hospital Perspective Ann. Thorac. Surg., September 1, 1995; 60(3): 824 - 832. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |